HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

demethyleneberberine

structure in first source

Also Known As:

demethyleneberberine chloride

Networked: 10 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Benzylisoquinolines: 151
    - Berberine Alkaloids: 9
      - Berberine: 2524
        demethyleneberberine: 10
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Berberine Alkaloids: 9
      - Berberine: 2524
        demethyleneberberine: 10

Experts

1.	Zhang, Miao: 4 articles (03/2020 - 01/2015)
2.	Zhang, Yubin: 4 articles (03/2020 - 01/2015)
3.	Li, Ruiyan: 3 articles (03/2020 - 01/2015)
4.	Zhou, Cuisong: 3 articles (03/2020 - 01/2015)
5.	Chen, Huan: 3 articles (06/2016 - 01/2015)
6.	Qiang, Xiaoyan: 3 articles (06/2016 - 01/2015)
7.	Zhao, Zheng: 3 articles (06/2016 - 01/2015)
8.	Gupta, Saurabh: 2 articles (10/2022 - 08/2021)
9.	Yan, Yan: 2 articles (02/2017 - 06/2016)
10.	Wang, Yongchen: 2 articles (06/2016 - 04/2016)

Related Diseases

1.	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/01/2015 - "Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model." 02/01/2017 - "Demethyleneberberine (DMB), a component of CPC, was reported to treat alcoholic liver disease as a novel natural mitochondria-targeted antioxidant in our previous study. "
2.	Non-alcoholic Fatty Liver Disease 04/15/2016 - "Here we introduce a natural product, demethyleneberberine (DMB), which potentially ameliorated NAFLD by activating AMPK pathways. " 04/15/2016 - "Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress."
3.	Mitochondrial Diseases (Mitochondrial Disease) 01/01/2015 - "Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model."
4.	Autoimmune Hepatitis 03/01/2020 - "Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling."
5.	Neurodegenerative Diseases (Neurodegenerative Disease) 10/01/2022 - "This review focus on the neuroprotective potential of demethyleneberberine in neurodegenerative disorders by attenuating different pathways, i.e., NF-κB, MAPK, and AMPK signalling." 10/01/2022 - "However, neither the pharmacological action nor the molecular mechanism of action of demethyleneberberine on neurodegenerative disorders has been explored yet. " 10/01/2022 - "Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight." 10/01/2022 - "A systematic literature review of PubMed, Medline, Bentham, Scopus, and EMBASE (Elseveier) databases was carried out with the help of keywords like "Demethyleneberberine; neuroinflammation; oxidative stress; Neuroprotective; Neurodegenerative disorders" till date. "

Related Drugs and Biologics

1.	Antioxidants
2.	cytidylyl-(3'-5')-cytidine (CpC)
3.	Inflammasomes
4.	Concanavalin A
5.	Berberine